M-37
Studies on virtual whole-blood infection assays
01/10/2021
S. Timme, P. Rudolph, K. Hünniger, I. Jacobsen, O. Kurzai, M. T. Figge
M-39
Design of an optimal COVID-19 surveillance protocol for child care facilities using an infection spread model
01/10/2021
P. Rudolph, J. Forster, S. Timme , J. G. Liese, O. Kurzai, M.T. Figge
M-35
Comparative simulations of fungal infection dynamics in the human and murine lung
01/10/2021
C. Saffer, S. Timme, M. T. Figge
M-38
DynaCoSys: Dynamic model of the complement system to understand pathogen immune evasion
01/10/2021
A. Tille,P. Rudolph,S. Timme, P. F. Zipfel, M. T. Figge
M-34
Hybrid agent-based modeling framework to simulate A. fumigatus infection scenario in the lung
01/10/2021
C. Saffer, S. Timme, M. T. Figge
IA-56
JIPipe: Designing automated image analysis pipelines without programming
22/07/2021 ELMI 2021
R. Gerst, Z. Cseresnyes, M.T. Figge
IbSB-11
Virtual phagocytosis assays reveal strain‐specific differences in the microscopic parameters of the interaction between alveolar macrophages and two A. fumigatus strains
08/10/2020 IbSB 2020
Sandra Timme, Jan‐Philipp Praetorius, Mohamed Hassan, Kerstin Voigt, ZoltánCseresnyés, Marc Thilo Figge
IA-54
MSOT cluster analysis toolkit to objectively assess pharmacokinetics and biodistribution of clinical biomarkers
01/09/2020
B. Hoffmann, R. Gerst, Z. Cseresnyés, W. Foo, O. Sommerfeld , A. T. Press, M. Bauer, M. T. Figge
IA-52
MISA++: a standardized interface for automatedhigh-performance big volume image analysis
04/03/2020 NEUBIAS 2020
R. Gerst, A. Medyukhina, M. T. Figge
IA-55
Quantitative image analysis of label-free cells
01/01/2020
Z. Cseresnyes, M. Hassan, K. Voigt, M.T. Figge